PATENT CLAIM ANALYSIS

Application Number: 15984728
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "210210"]

Abstract:
Compounds and salts thereof that are useful as JAK kinase inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.

Claim (Index 10):
A compound which is: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 93.0
- Lexical Diversity: 1.40909
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15984747', '15139164', '15861688', '14670425', '15257926']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8320810076324606
- 35 USC 102 Novelty (BERT): 0.5559430823975465
- Combined Prediction Score: 0.8044672151089692
- Mean Citation Score: 401.70719
- Max Citation Score: 431.15952
- Similarity Product: 347.35878264787675

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test